Condition
    Strong Evidence
    Effectiveness 3/5

    Omega-3 Fatty Acids for Eczema (Atopic Dermatitis)

    Trials of omega-3 in atopic dermatitis show mixed results, with some reporting reduced severity scores at 2-3g of EPA and DHA daily and others finding no difference. Reasonable to try as an adjunct; not a replacement for emollients or topical therapy.

    Overview

    Trials of omega-3 in atopic dermatitis show mixed results, with some reporting reduced severity scores at 2-3g of EPA and DHA daily and others finding no difference. Reasonable to try as an adjunct; not a replacement for emollients or topical therapy.

    Verdict

    Mixed evidence

    How It Works

    Atopic dermatitis involves both barrier dysfunction and Th2-skewed inflammation. Omega-3 fatty acids compete with arachidonic acid for cyclooxygenase and lipoxygenase, lowering production of leukotriene B4 and prostaglandin E2, and generate resolvins that actively resolve inflammation. There is also a barrier argument: essential fatty acids contribute to the lipid lamellae of the stratum corneum, and disordered fatty acid metabolism has been described in atopic skin. Neither route addresses filaggrin mutations, which underlie a substantial proportion of moderate-to-severe eczema.

    Dosing & Protocol

    Typical dose

    Recommended dose
    2000-3000mg EPA+DHA daily with meals
    Expected timeframe
    12-16 weeks

    Protocol

    form
    High-EPA fish oil or algal oil
    duration
    12-16 weeks with a SCORAD or POEM score at baseline and end
    co factor
    Take with dietary fat and continue emollients and topical corticosteroids as prescribed. Evidence is mixed: a small trial of 5.4 g EPA daily reduced SCORAD modestly, but pooled analyses are inconsistent and the effect is far smaller than topical treatment.
    titration
    Increase to 2000-3000 mg/day over two to four weeks - the eczema trials used 1.8-5.4 g/day of EPA
    starting dose
    1000 mg combined EPA+DHA daily with a meal

    Evidence

    What the studies say

    A German randomised, double-blind trial found that 5.4g of DHA daily for eight weeks reduced SCORAD severity scores compared with an isoenergetic control, and several smaller trials report improvement in itch and severity. Other randomised trials, including studies of maternal supplementation for infant eczema prevention, found no significant effect, and Cochrane reviews of dietary supplements in eczema conclude the evidence is insufficient. The literature is heterogeneous in dose, duration and severity scoring, and many trials are underpowered. Emollient therapy, topical anti-inflammatories and trigger avoidance remain the foundation of care. Omega-3 is low-risk and may offer a small additive benefit over several months.

    No studies are yet linked to both Omega-3 Fatty Acids and Eczema (Atopic Dermatitis).

    Safety

    Caveats

    Omega-3 is adjunctive - do not reduce emollients, topical corticosteroids or calcineurin inhibitors. Weeping, crusted or painful eczema may be infected and needs medical treatment. Safety ceiling: 3 g/day EPA+DHA is the point above which medical supervision is needed for bleeding risk, relevant with warfarin, DOACs, aspirin and clopidogrel; stop before surgery. Fish allergy commonly coexists with atopy - use algal oil. Standard doses acceptable in pregnancy; avoid cod liver oil because of vitamin A.

    Less likely to help if

    People with severe or infected eczema needing systemic therapy, and those with a clear contact-allergen trigger.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.